news roundup
Patient reminders tool features a two-way messaging dashboard and a mobile app compatible with iPhone and Android devices.
|
advertisment
BIOVISUALIZATION
Effective Mining and Interpretation of Laboratory Results Data
On Demand
 Learn more
|
Bioclinica releases OnPoint Direct CTMS is an out-of-the-box solution featuring full CTMS function at a cost-friendly price point.
|
advertisment
ICH E6 (R2) Process and Technology Considerations for the New Risk Based Gold Standard
On Demand
 Learn more
|
Bracket’s Patient Diary allows for clinical trial participants to record information using their smartphone. Bracket has also updated its Bracket RTSM platform and has released an analytics platform.
|
advertisment
Keeping pace with immuno-oncology research breakthroughs and biomarker identification
On Demand
 Learn more
|
Includes promotions, new hires and awards or recognition from the clinical trials industry.
|
|
|
advertisment
|
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Risk-Based Monitoring
Identifying and defining right Key Risk Indicators (KRIs) is important to measure and monitor risks correctly during the conduct phase.
The analysis in this article demonstrates that the structure of RACT questions infers subjectivity.
Make plans now to attend CBI's Risk-Based Trial Management and Monitoring event in November.
|
Blog Posts
The Janssen Autism Knowledge Engine (JAKE™) was developed to advance clinical research in autism by integrating emerging technologies into traditional clinical trial processes.
In every country of the continent the needs will persist at the human and public health level for more effective medicines, and for more effective ways of paying for them.
What does innovation mean to you? Is your company innovating? Let us know!
|
|
|
Articles
This article describes the value in taking data and using them early on in the service of patient recruitment and enrollment.
Perhaps the most expensive impact of one substantial protocol amendment is the unplanned incremental cycle time tacked on to the study.
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
